Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0075560
DC FieldValue
dc.titleBofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
dc.contributor.authorAzushima K.
dc.contributor.authorTamura K.
dc.contributor.authorWakui H.
dc.contributor.authorMaeda A.
dc.contributor.authorOhsawa M.
dc.contributor.authorUneda K.
dc.contributor.authorKobayashi R.
dc.contributor.authorKanaoka T.
dc.contributor.authorDejima T.
dc.contributor.authorFujikawa T.
dc.contributor.authorYamashita A.
dc.contributor.authorToya Y.
dc.contributor.authorUmemura S.
dc.date.accessioned2020-03-31T03:00:43Z
dc.date.available2020-03-31T03:00:43Z
dc.date.issued2013
dc.identifier.citationAzushima K., Tamura K., Wakui H., Maeda A., Ohsawa M., Uneda K., Kobayashi R., Kanaoka T., Dejima T., Fujikawa T., Yamashita A., Toya Y., Umemura S. (2013). Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity. PLoS ONE 8 (10) : e75560. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0075560
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/166190
dc.description.abstractAccumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disease. Therefore, an effective anti-obesity treatment with a concomitant improvement in metabolic profile is important for the treatment of metabolic dysfunction with visceral obesity. Bofu-tsu-shosan (BOF) is one of oriental herbal medicine and is clinically available to treat obesity in Japan. Although BOF is a candidate as a novel therapeutic strategy to improve metabolic dysfunction with obesity, the mechanism of its beneficial effect is not fully elucidated. Here, we investigated mechanism of therapeutic effects of BOF on KKAy mice, a model of human metabolic disorders with obesity. Chronic treatment of KKAy mice with BOF persistently decreased food intake, body weight gain, low-density lipoprotein cholesterol and systolic blood pressure. In addition, both tissue weight and cell size of white adipose tissue (WAT) were decreased, with concomitant increases in the expression of adiponectin and peroxisome proliferator-activated receptors genes in WAT as well as the circulating adiponectin level by BOF treatment. Furthermore, gene expression of uncoupling protein-1, a thermogenesis factor, in brown adipose tissue and rectal temperature were both elevated by BOF. Intriguingly, plasma acylated-ghrelin, an active form of orexigenic hormone, and short-term food intake were significantly decreased by single bolus administration of BOF. These results indicate that BOF exerts a combinatorial favorable metabolic modulation including antihypertensive effect, at least partially, via its beneficial effect on adipose tissue function and its appetite-inhibitory property through suppression on the ghrelin system. © 2013 Azushima et al.
dc.publisherPublic Library of Science
dc.sourceUnpaywall 20200320
dc.subjectadiponectin
dc.subjectbofu tsu shosan
dc.subjectghrelin
dc.subjectherbaceous agent
dc.subjectlow density lipoprotein cholesterol
dc.subjectperoxisome proliferator activated receptor alpha
dc.subjectperoxisome proliferator activated receptor gamma
dc.subjectplasma acylated ghrelin
dc.subjectunclassified drug
dc.subjectuncoupling protein 1
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectantihypertensive activity
dc.subjectarticle
dc.subjectbrown adipose tissue
dc.subjectcell size
dc.subjectcholesterol blood level
dc.subjectcontrolled study
dc.subjectdrug mechanism
dc.subjectfood intake
dc.subjectgene expression
dc.subjectheart rate
dc.subjectherbal medicine
dc.subjecthypertension
dc.subjectintraabdominal fat
dc.subjectlong term care
dc.subjectmale
dc.subjectmetabolic disorder
dc.subjectmouse
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectnonhuman
dc.subjectobesity
dc.subjectprotein blood level
dc.subjectrectum temperature
dc.subjectsystolic blood pressure
dc.subjecttissues
dc.subjectvisceral obesity
dc.subjectweight gain
dc.subjectwhite adipose tissue
dc.subjectAnimals
dc.subjectBlood Pressure
dc.subjectDisease Models, Animal
dc.subjectDrugs, Chinese Herbal
dc.subjectHerbal Medicine
dc.subjectHumans
dc.subjectIon Channels
dc.subjectMetabolic Diseases
dc.subjectMice
dc.subjectMitochondrial Proteins
dc.subjectObesity, Abdominal
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1371/journal.pone.0075560
dc.description.sourcetitlePLoS ONE
dc.description.volume8
dc.description.issue10
dc.description.pagee75560
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0075560.pdf2.61 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.